BTBD17

 

Full name: BTB domain containing 17 Alias Symbol: LGALS3BPL|BTBD17A|TANGO10A
Type: protein-coding gene Cytoband: 17q25.1
Entrez ID: 388419 HGNC ID: HGNC:33758 Ensembl Gene: ENSG00000204347 OMIM ID: 
Drug and gene relationship at DGIdb

 

Expression of BTBD17:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 BTBD17 388419 230445_at 0.0803 0.7312
GSE26886 BTBD17 388419 230445_at 0.2458 0.0339
GSE45670 BTBD17 388419 230445_at -0.0156 0.9054
GSE53622 BTBD17 388419 10499 -0.1275 0.2228
GSE53624 BTBD17 388419 10499 0.0774 0.6217
GSE63941 BTBD17 388419 230445_at 0.1991 0.2219
GSE77861 BTBD17 388419 230445_at -0.1133 0.4758
TCGA BTBD17 388419 RNAseq -1.5060 0.1745

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by BTBD17 expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of BTBD17:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 BTBD17 388419 3 2 25
GSE20123 BTBD17 388419 3 2 25
GSE43470 BTBD17 388419 5 3 35
GSE46452 BTBD17 388419 33 0 26
GSE47630 BTBD17 388419 8 1 31
GSE54993 BTBD17 388419 2 5 63
GSE54994 BTBD17 388419 10 4 39
GSE60625 BTBD17 388419 6 0 5
GSE74703 BTBD17 388419 5 1 30
GSE74704 BTBD17 388419 3 1 16
TCGA BTBD17 388419 32 10 54

Total number of gains: 110; Total number of losses: 29; Total Number of normals: 349.  


 

Somatic mutations of BTBD17:

 

Generating mutation plots.

 

Highly correlated genes for BTBD17:

 

Showing top 20/99 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
BTBD17AFMID0.705989303
BTBD17SHOX20.700152303
BTBD17CATSPER30.691682303
BTBD17CCT8L20.68414404
BTBD17PKLR0.668029303
BTBD17LINC011690.660386303
BTBD17PLD40.658246303
BTBD17CLEC4M0.654347403
BTBD17NTSR10.648329303
BTBD17ITGA2B0.646367303
BTBD17LINC003110.645699303
BTBD17ACHE0.643365303
BTBD17SLC8A30.641661303
BTBD17FCGR1A0.638503303
BTBD17SIX60.630014404
BTBD17SYP0.625109303
BTBD17HHIP0.625072303
BTBD17XIRP20.624752303
BTBD17CCR100.623642403
BTBD17SNX80.6211303

For details and further investigation, click here